-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
MiNK Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q3 2020 to Q3 2025.
- MiNK Therapeutics, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$3.18M, a 68.9% decline year-over-year.
- MiNK Therapeutics, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$12.4M, a 12.9% increase year-over-year.
- MiNK Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$11.3M, a 50.8% increase from 2023.
- MiNK Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$22.9M, a 25.9% increase from 2022.
- MiNK Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$30.9M, a 9.14% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)